| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Long-term survival in three patients with metastatic non-small cell lung cancer treated with gefitinib.
|
Lung Cancer
|
2006
|
2.08
|
|
2
|
Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
|
Cancer Res
|
2005
|
1.28
|
|
3
|
Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells.
|
Lung Cancer
|
2005
|
1.24
|
|
4
|
Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer.
|
Cancer Lett
|
2003
|
1.15
|
|
5
|
Expression and functional analyses of breast cancer resistance protein in lung cancer.
|
Clin Cancer Res
|
2003
|
1.15
|
|
6
|
Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts.
|
Life Sci
|
2007
|
1.07
|
|
7
|
The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells.
|
Mol Cancer Ther
|
2004
|
1.00
|
|
8
|
Spontaneous remission of a non-small cell lung cancer possibly caused by anti-NY-ESO-1 immunity.
|
Lung Cancer
|
2009
|
0.99
|
|
9
|
Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
|
Int J Cancer
|
2002
|
0.98
|
|
10
|
Pulmonary mucormycosis (Cunninghamella bertholletiae) with cavitation diagnosed using ultra-thin fibre-optic bronchoscopy.
|
Respirology
|
2008
|
0.97
|
|
11
|
Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.
|
Int J Cancer
|
2004
|
0.96
|
|
12
|
Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.
|
Lung Cancer
|
2007
|
0.95
|
|
13
|
Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells.
|
Int J Cancer
|
2004
|
0.94
|
|
14
|
BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer.
|
Cancer Chemother Pharmacol
|
2006
|
0.89
|
|
15
|
Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma.
|
Cancer Lett
|
2006
|
0.89
|
|
16
|
Interstitial pneumonia probably associated with sorafenib treatment: An alert of an adverse event.
|
Lung Cancer
|
2009
|
0.89
|
|
17
|
Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma.
|
Lung Cancer
|
2006
|
0.87
|
|
18
|
Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropenia.
|
J Thorac Oncol
|
2011
|
0.87
|
|
19
|
Pharmacokinetics of gefitinib predicts antitumor activity for advanced non-small cell lung cancer.
|
J Thorac Oncol
|
2010
|
0.87
|
|
20
|
Mycobacterium intracellulare pulmonary infection which co-existed and mimicked lung cancer.
|
Intern Med
|
2008
|
0.86
|
|
21
|
Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells.
|
Cancer
|
2008
|
0.86
|
|
22
|
Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma.
|
Leuk Lymphoma
|
2006
|
0.85
|
|
23
|
High-risk populations for nasal carriage of methicillin-resistant Staphylococcus aureus.
|
J Infect Chemother
|
2004
|
0.85
|
|
24
|
Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines.
|
Int J Cancer
|
2003
|
0.84
|
|
25
|
Tubular adenocarcinoma of the thymus: case report and review of the literature.
|
Int J Surg Pathol
|
2006
|
0.84
|
|
26
|
Relationship between whole-blood interferon-gamma production and extent of radiographic disease in patients with pulmonary tuberculosis.
|
Diagn Microbiol Infect Dis
|
2003
|
0.84
|
|
27
|
Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer.
|
Cancer Chemother Pharmacol
|
2004
|
0.84
|
|
28
|
Mediastinal signet-ring cell carcinoma of unknown primary: long-term survival by treatment with S-1, a novel derivative of 5-fluorouracil.
|
Lung Cancer
|
2007
|
0.82
|
|
29
|
Multiple gammac-receptor expression in adult T-cell leukemia.
|
Eur J Haematol
|
2002
|
0.82
|
|
30
|
Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer: a multiinstitutional phase 2 study.
|
Cancer
|
2007
|
0.82
|
|
31
|
Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer.
|
Cancer Chemother Pharmacol
|
2010
|
0.82
|
|
32
|
Thymic carcinoma with epidermal growth factor receptor gene mutations.
|
Lung Cancer
|
2006
|
0.80
|
|
33
|
Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy.
|
Support Care Cancer
|
2014
|
0.79
|
|
34
|
Effect of ionic liquid weight ratio on pretreatment of bamboo powder prior to enzymatic saccharification.
|
Bioresour Technol
|
2012
|
0.79
|
|
35
|
Antiproliferative effects of gefitinib are associated with suppression of E2F-1 expression and telomerase activity.
|
Anticancer Res
|
2006
|
0.79
|
|
36
|
Induction chemotherapy with cisplatin, vinorelbine, and mitomycin-C followed by surgery for patients with pathologic N2 non-small-cell lung cancer.
|
Clin Lung Cancer
|
2008
|
0.78
|
|
37
|
[An adult case of influenza-associated encephalitis successfully treated with high dose intravenous immunoglobulins].
|
Kansenshogaku Zasshi
|
2012
|
0.78
|
|
38
|
Expression of heat shock protein (Hsp) 70 and Hsp 40 in colorectal cancer.
|
Med Oncol
|
2003
|
0.77
|
|
39
|
Interruption of p16 gene expression in adult T-cell leukaemia/lymphoma: clinical correlation.
|
Br J Haematol
|
2003
|
0.77
|
|
40
|
Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer.
|
Cancer Chemother Pharmacol
|
2012
|
0.77
|
|
41
|
[Two cases of acute respiratory distress syndrome related to zinc fumes and zinc dust inhalation].
|
J UOEH
|
2014
|
0.77
|
|
42
|
A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
|
J Thorac Oncol
|
2009
|
0.76
|
|
43
|
Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells.
|
Lung Cancer
|
2005
|
0.76
|
|
44
|
Different epidermal growth factor receptor gene mutations in a patient with 2 synchronous lung cancers.
|
Clin Lung Cancer
|
2007
|
0.75
|
|
45
|
Phase I study of irinotecan and gemcitabine in previously untreated patients with advanced non-small cell lung cancer.
|
Jpn J Clin Oncol
|
2007
|
0.75
|
|
46
|
Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer.
|
Respirology
|
2007
|
0.75
|
|
47
|
[A case of brain metastasis discovered after surgery for lung cancer based on changes in CEA, in which long-term survival was obtained by repeated gammaknife irradiation].
|
Nihon Kokyuki Gakkai Zasshi
|
2005
|
0.75
|
|
48
|
Mucosa-associated lymphoid tissue lymphoma of the thymus associated with Sjögren's syndrome: report of a case.
|
Surg Today
|
2008
|
0.75
|
|
49
|
Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer.
|
Cancer Chemother Pharmacol
|
2007
|
0.75
|
|
50
|
Necrotizing pneumonia due to femoral osteomyelitis caused by community-acquired methicillin-resistant Staphylococcus aureus.
|
Intern Med
|
2013
|
0.75
|
|
51
|
Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reports.
|
Lung Cancer
|
2005
|
0.75
|
|
52
|
Gefitinib increases serum concentrations of oral irinotecan and SN-38 without increasing the biliary concentration of SN-38 in rats.
|
Chemotherapy
|
2008
|
0.75
|
|
53
|
[Anticancer drugs and ABC transporters].
|
Gan To Kagaku Ryoho
|
2005
|
0.75
|
|
54
|
Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer.
|
Clin Lung Cancer
|
2012
|
0.75
|
|
55
|
Chronic necrotizing pulmonary aspergillosis following cryptococcal infection of the lung.
|
Scand J Infect Dis
|
2005
|
0.75
|
|
56
|
A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
|
Cancer Chemother Pharmacol
|
2006
|
0.75
|
|
57
|
Changes in Immunohistochemical Protein Levels in Anaplastic Lymphoma Kinase-positive Lung Adenocarcinoma Possibly due to Chemo-radiotherapy.
|
Intern Med
|
2016
|
0.75
|
|
58
|
Pulmonary Artery Sarcoma Overexpressing Platelet-derived Growth Factor Receptor α.
|
Intern Med
|
2017
|
0.75
|
|
59
|
A fatal case of acute myocardial infarction following the improvement of influenza A(H1N1)pdm2009-related acute myocarditis.
|
Intern Med
|
2014
|
0.75
|
|
60
|
[Case of pulmonary adenocarcinoma with co-existing pulmonary actinomycosis in one region of the lung].
|
Nihon Kokyuki Gakkai Zasshi
|
2009
|
0.75
|